April 2016

New Product - Methylene Blue Injection

Methylene Blue Injection (methylene blue trihydrate) is indicated for the treatment of drug induced methaemoglobinaemia; for the treatment of idiopathic methaemoglobinaemia (in which a structural abnormality of haemoglobin is not present); as a bacteriological stain; as a dye in diagnostic procedures such as fistula detection; and for the delineation of certain body tissues during surgery. Methylene Blue Injection is contraindicated in thiazide dye hypersensitivity, glucose-6-phosphate dehydrogenase deficiency, severe renal impairment, methaemoglobinaemia due to chlorate poisoning, and in methaemoglobinaemia during treatment of cyanide poisoning. Intrathecal and subcutaneous injection of methylene blue is also contraindicated. Methylene Blue Injection is available as a 50 mg/5 mL vial in packs of 10’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629